Drawing for F.A.S.T.

USPTO serial 77674401

F.A.S.T.

Reviewed by CopyMark Law Group

Reg. 3878476Status 710
Filing date
Status date
Registration date
Nov 23, 2010
Examiner
GUTTADAURO, JULIE MARIE
Law office
TMEG LAW OFFICE 106

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with F.A.S.T.?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Michael F. Snyder

MICHAEL F. SNYDER VOLPE AND KOENIG, P.C.30 South 17th StreetSuite 1800PHILADELPHIA, PA 19103

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations, namely, pharmaceutical agents for biomolecular therapy; pharmaceutical preparations for the treatment of allergies, arthritis, auto-immune diseases and disorders, bowel diseases and disorders, cancer, cardiovascular diseases and disorders, central nervous system diseases and disorders, dermatologic diseases and disorders, endocrine system diseases and disorders, gastro-intestinal diseases, immunological diseases and disorders, inflammation, inflammatory diseases, metabolic disorders, neurologic disorders, osteoporosis, pain, proliferative diseases, tissue diseases, and tumorous diseases, in man or animals; pharmaceutical anti-inflammatory, healing and wound healing agents; chemical, biological and biochemical preparations for medical and veterinary purposes, namely, amino acids and extracellular matrix compoundsSECTION 8 - CANCELLEDJan 3, 2008

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 25, 2021CAEXCANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9—
Nov 23, 2019REM2COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED—
Jan 19, 2018NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Jan 19, 2018C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Jan 12, 2018EROPTEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED—
Jul 14, 2017PR23POST REGISTRATION ACTION MAILED - SEC. 8 & 15—
Jul 14, 2017APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
May 24, 2017ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
May 22, 2017815FREGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED—
May 22, 2017E815TEAS SECTION 8 & 15 RECEIVED—
Jan 9, 2013ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Nov 23, 2010R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Sep 7, 2010PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 18, 2010NPUBNOTICE OF PUBLICATION—
Aug 3, 2010PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Aug 3, 2010ALIEASSIGNED TO LIE—
Jul 21, 2010CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 20, 2010TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 19, 2010CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 19, 2010TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 19, 2010CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 16, 2010CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 15, 2009TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 15, 2009CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 15, 2009ALIEASSIGNED TO LIE—
Nov 30, 2009TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 28, 2009CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 27, 2009CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 12, 2009DOCKASSIGNED TO EXAMINER—
Feb 25, 2009MPMKNOTICE OF PSEUDO MARK MAILED—
Feb 24, 2009NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—

Frequently asked questions

Related guidance